Scientists identify molecular pathway that helps moving cells avoid aimless wandering

Findings from Johns Hopkins Medicine study have potential implications for understanding cancer cell spread

01-Apr-2021 - Working with fruit flies, scientists at Johns Hopkins Medicine say they have identified a new molecular pathway that helps steer moving cells in specific directions. The set of interconnected proteins and enzymes in the pathway act as steering and rudder components that drive cells toward an ...

The self-curving cornea

Cultivating 4D tissues

21-Jan-2019 - Scientists at Newcastle University have developed a biological system which lets cells form a desired shape by moulding their surrounding material - in the first instance creating a self-curving cornea. The cornea is the clear outer layer at the front of the eye ball. In the research, a flat ...

3D 'organ on a chip' could accelerate search for new disease treatments

30-Oct-2018 - Researchers have developed a three-dimensional 'organ on a chip' which enables real-time continuous monitoring of cells, and could be used to develop new treatments for disease while reducing the number of animals used in research. The device, which incorporates cells inside a 3D transistor made ...

UF scientists find first link in humans between memory and nerve cell production

26-Aug-2010 - Production of new nerve cells in the human brain is linked to learning and memory, according to a new study from the University of Florida. The research is the first to show such a link in humans. The findings, published in the journal Brain, provide clues about processes involved in age- and ...

Blocking tumor's 'death switch' paradoxically stops tumor growth

27-May-2010 - Every cell contains machinery for self-destruction, used to induce death when damaged or sick. But according to a new research study, a receptor thought to mediate cell suicide in normal cells may actually be responsible for the unrestrained growth of cancerous tumors. Blocking the activity of ...

First successful use of expanded umbilical-cord blood units to treat leukemia

20-Jan-2010 - Scientists at Fred Hutchinson Cancer Research Center have cleared a major technical hurdle to making umbilical-cord-blood transplants a more widely-used method for treating leukemia and other blood cancers. In a study published in Nature Medicine , Colleen Delaney, M.D., and colleagues describe ...

BD Biosciences and StemCell Technologies Sign License Agreements with WARF

Commercialization of Novel Culture Media and Surfaces for Human Embryonic Stem Cell Research

19-Jun-2007 - BD Biosciences, a segment of global medical technology company BD (Becton, Dickinson and Company), and StemCell Technologies, Inc. announced that they have each entered into a worldwide license agreement with the Wisconsin Alumni Research Foundation (WARF). The agreements will allow BD ...

Cellexus Biosystems appoints Dr Julie Bick as its US-based Chief Scientific Officer

29-Mar-2007 - Cellexus Biosystems PLC announced that it has appointed Dr Julie Bick as its Chief Scientific Officer. Dr Bick has the world-wide responsibility for leading the Company's research and customer support programmes and will be based in the US from its wholly own subsidiary, Cellexus Biosystems ...

Prodo Laboratories, Inc. and Invenio Institute Launched as New Diabetes Research Companies

20-Nov-2006 - Two new diabetes companies, Prodo Laboratories, Inc. and Invenio Institute, announced their launch at the Rachmiel Levine Diabetes and Obesity Symposium. Prodo Laboratories, Inc., a privately held biopharmaceutical company located in Irvine, CA, will provide primary human islets as a research ...

Massachusetts Eye and Ear Infirmary to evaluate Stem Cell Innovation's PluriCells for hearing research

12-Oct-2006 - Stem Cell Innovations, Inc. announced that the Company will collaborate with Massachusetts Eye and Ear Infirmary (MEEI). Under the material transfer agreement, MEEI will evaluate PluriCells for their capacity to form the human tissues implicated in hearing loss. In return SCI will receive a ...